SYMPTOMATIC SEVERE AORTIC STENOSIS
Clinical trials for SYMPTOMATIC SEVERE AORTIC STENOSIS explained in plain language.
Never miss a new study
Get alerted when new SYMPTOMATIC SEVERE AORTIC STENOSIS trials appear
Sign up with your email to follow new studies for SYMPTOMATIC SEVERE AORTIC STENOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New heart valve offers hope for High-Risk patients
Disease control OngoingThis study tests a next-generation heart valve (Navitor) in 333 people with severe aortic stenosis who are too high-risk for open-heart surgery. The goal is to see if the valve is safe and works well at 30 days, focusing on survival and reducing leaks around the valve. The valve …
Matched conditions: SYMPTOMATIC SEVERE AORTIC STENOSIS
Phase: NA • Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New heart valve procedure shows promise for severe aortic stenosis
Disease control OngoingThis study tests a new heart valve called the NAVITOR, placed using a thin tube (catheter) without open-heart surgery. It includes 434 people with severe aortic stenosis who are at intermediate or low risk for surgery. The main goals are to check for leaks around the valve at 30 …
Matched conditions: SYMPTOMATIC SEVERE AORTIC STENOSIS
Phase: NA • Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New Balloon-Expandable heart valve tested in just 8 patients
Disease control OngoingThis early study is testing a new balloon-expandable heart valve device (TAVI) in 8 people with severe aortic stenosis who are at increased surgical risk. The goal is to see if the device can be safely delivered and perform as intended. Because this is a first-in-human study with…
Matched conditions: SYMPTOMATIC SEVERE AORTIC STENOSIS
Phase: NA • Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New heart valve device tested in tiny early study
Disease control OngoingThis early study is testing a new balloon-expandable heart valve system from Abbott for people with severe, symptomatic aortic stenosis. The valve is delivered through a catheter, avoiding open-heart surgery. Only 11 participants are enrolled to check if the device is safe and wo…
Matched conditions: SYMPTOMATIC SEVERE AORTIC STENOSIS
Phase: NA • Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC